PDS Biotechnology Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $41.0M | $56.6M |
| FY2024 | — | $37.2M | $41.7M |
| FY2025 | — | $22.4M | $26.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $41.0M | $56.6M |
| FY2024 | — | $37.2M | $41.7M |
| FY2025 | — | $22.4M | $26.7M |